A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

NCT07409181 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: BI 3000202
DRUG: Placebo

Sponsor

Boehringer Ingelheim